FI71165C - Foerfarande foer framstaellning av toxoplasma-antigen undersoekning av toxoplasma-immunitet - Google Patents
Foerfarande foer framstaellning av toxoplasma-antigen undersoekning av toxoplasma-immunitet Download PDFInfo
- Publication number
- FI71165C FI71165C FI824280A FI824280A FI71165C FI 71165 C FI71165 C FI 71165C FI 824280 A FI824280 A FI 824280A FI 824280 A FI824280 A FI 824280A FI 71165 C FI71165 C FI 71165C
- Authority
- FI
- Finland
- Prior art keywords
- antigen
- cells
- toxoplasma
- culture
- toxoplasms
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title claims description 39
- 108091007433 antigens Proteins 0.000 title claims description 38
- 102000036639 antigens Human genes 0.000 title claims description 38
- 241000223996 Toxoplasma Species 0.000 title description 22
- 210000004027 cell Anatomy 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 230000036039 immunity Effects 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 244000309466 calf Species 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 230000009849 deactivation Effects 0.000 claims description 4
- 241000223997 Toxoplasma gondii Species 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 2
- 210000001840 diploid cell Anatomy 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 210000004102 animal cell Anatomy 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 8
- 244000045947 parasite Species 0.000 description 5
- 241000700198 Cavia Species 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 3
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 2
- 210000003567 ascitic fluid Anatomy 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 238000009589 serological test Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101000662009 Homo sapiens UDP-N-acetylglucosamine pyrophosphorylase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 102100037921 UDP-N-acetylglucosamine pyrophosphorylase Human genes 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 231100001221 nontumorigenic Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011110 re-filtration Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8123565 | 1981-12-17 | ||
| FR8123565A FR2518407A1 (fr) | 1981-12-17 | 1981-12-17 | Nouvel antigene pour la recherche de l'immunite toxoplasmique et son procede de preparation |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI824280A0 FI824280A0 (fi) | 1982-12-14 |
| FI824280L FI824280L (fi) | 1983-06-18 |
| FI71165B FI71165B (fi) | 1986-08-14 |
| FI71165C true FI71165C (fi) | 1986-11-24 |
Family
ID=9265121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI824280A FI71165C (fi) | 1981-12-17 | 1982-12-14 | Foerfarande foer framstaellning av toxoplasma-antigen undersoekning av toxoplasma-immunitet |
Country Status (11)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2564731B1 (fr) * | 1984-05-28 | 1986-10-10 | Ambroise Thomas Pierre | Nouvelles fractions exo-antigeniques toxoplasmiques, leur procede de preparation et leur application a la recherche de l'immunite toxoplasmique chez l'homme par tests cutanes |
| FR2618680B1 (fr) * | 1987-07-31 | 1990-05-11 | Pasteur Institut | Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques |
| FR2625099B1 (fr) * | 1987-12-24 | 1991-06-14 | Transgene Sa | Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose |
| ES2342971T3 (es) | 2005-03-08 | 2010-07-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Antigenos recombinantes quimericos de toxoplasma gondii. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5444016A (en) * | 1977-09-13 | 1979-04-07 | Nippon Touketsu Kansou Kenkiyu | Latex coagulation and reaction reagent for detecting toxoplasma antibody and production thereof |
| FR2482980A1 (fr) * | 1980-05-20 | 1981-11-27 | Biomerieux Sa | Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues |
-
1981
- 1981-12-17 FR FR8123565A patent/FR2518407A1/fr active Granted
-
1982
- 1982-12-02 AT AT82402197T patent/ATE14274T1/de active
- 1982-12-02 DE DE8282402197T patent/DE3264792D1/de not_active Expired
- 1982-12-02 EP EP82402197A patent/EP0082745B1/fr not_active Expired
- 1982-12-10 AR AR291563A patent/AR228806A1/es active
- 1982-12-10 AU AU91404/82A patent/AU554541B2/en not_active Ceased
- 1982-12-13 ES ES518127A patent/ES518127A0/es active Granted
- 1982-12-14 JP JP57217930A patent/JPS58126814A/ja active Pending
- 1982-12-14 FI FI824280A patent/FI71165C/fi not_active IP Right Cessation
- 1982-12-16 NO NO824242A patent/NO824242L/no unknown
- 1982-12-16 CA CA000417915A patent/CA1206904A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3264792D1 (en) | 1985-08-22 |
| CA1206904A (en) | 1986-07-02 |
| AU554541B2 (en) | 1986-08-28 |
| NO824242L (no) | 1983-06-20 |
| AR228806A1 (es) | 1983-04-15 |
| ATE14274T1 (de) | 1985-08-15 |
| JPS58126814A (ja) | 1983-07-28 |
| FR2518407A1 (fr) | 1983-06-24 |
| EP0082745B1 (fr) | 1985-07-17 |
| ES8308485A1 (es) | 1983-09-01 |
| FI824280A0 (fi) | 1982-12-14 |
| FI824280L (fi) | 1983-06-18 |
| ES518127A0 (es) | 1983-09-01 |
| FR2518407B1 (enrdf_load_stackoverflow) | 1984-05-04 |
| AU9140482A (en) | 1983-06-23 |
| EP0082745A1 (fr) | 1983-06-29 |
| FI71165B (fi) | 1986-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ludwig et al. | Inhibition of herpes virus-induced cell fusion by concanavalin A, antisera, and 2-deoxy-D-glucose | |
| EP0043272A1 (en) | Production of viral antigens | |
| FI71165C (fi) | Foerfarande foer framstaellning av toxoplasma-antigen undersoekning av toxoplasma-immunitet | |
| Jenkins et al. | Development of resistance to coccidiosis in the absence of merogonic development using X-lrradiated Eimeria acervulina oocysts | |
| CA2149197A1 (en) | Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture | |
| Fujinami et al. | Failure to cleave measles virus fusion protein in lymphoid cells. A possible mechanism for viral persistence in lymphocytes | |
| US4400472A (en) | Novel rabies virus strain and a process for its preparation | |
| Hilleman | Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology | |
| NZ272921A (en) | Tissue culture produced live toxoplasma gondii bradyzoites, preparation, diagnosis and vaccines | |
| Banks et al. | Quantitation of immunoglobulin-bearing lymphocytes and lymphocyte response to mitogens in horses persistently infected by equine infectious anemia virus | |
| NZ533869A (en) | A method of production of purified Ross River virus antigen | |
| CN1301297A (zh) | 用于病毒繁殖和增殖的培养基和方法 | |
| Musser et al. | Measles virus growth in canine renal cell cultures | |
| Parkman et al. | Rubella virus: Isolation, characterization, and laboratory diagnosis | |
| US4619827A (en) | Method for administering equine vaccines and compositions therefor | |
| Buxton et al. | Primary and secondary responses of the ovine lymph node to Toxoplasma gondii: cell output in efferent lymph and parasite detection | |
| Krämer et al. | German experimental hepatitis B vaccine—influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers | |
| McNeill | The antibody response of rabbits to inactivated vaccinia virus | |
| DE69737198T2 (de) | Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung | |
| Liewes et al. | Optimization and kinetics of in vitro stimulation of carp (Cyprinus carpio L.) leukocytes | |
| Payne et al. | Vaccination of bursectomised chickens with inactivated Marek's disease virus‐specific antigens | |
| Johnson | Status of arenavirus vaccines and their application | |
| Bonin et al. | Calf serum content of various viral vaccines and possibilities for its reduction | |
| Hilleman et al. | Infectious hepatitis (hepatitis A) research in nonhuman primates | |
| Fosberg et al. | Isolation and characterization of epizootic hemorrhagic disease virus from white-tailed deer (Odocoileus virginianus) in eastern Washington |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: INSTITUT MERIEUX |